Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0000875320-26-000108 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-02-24 | VRTX | Biller Jonathan | EVP, CLO | F - Tax | $485.11 | -1,144 | 14.6K | -7% | -$555.0K | |
| 2026-02-26 | 2026-02-25 | VRTX | Biller Jonathan | EVP, CLO | S - Sale | $486.35 | -945 | 13.7K | -6% | -$459.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | F | D | 1,144 | $485.11 | 14,604 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-25 | S | D | 945 | $486.35 | 13,659 | D | — | — |